Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes. Mol Metab
The largest historical gains in Canadas human-capital portfolio are programmes already at scale
This mechanism promotes the regeneration of the intact skin layer, demonstrating excellent biocompatibility and healing-promoting potential
The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: a systematic review and meta-analysis
US$ 22.26
US$ 23.04
US$ 26.13
US$ 25.25
US$ 29.72
US$ 26.30
